Watchful Living in Improving Quality of Life in Participants With Localized Prostate Cancer on Active Surveillance and Their Partners

PRIMARY OBJECTIVES:

I. To determine the feasibility of recruiting and implementing a lifestyle intervention for prostate cancer patients and their partners.

SECONDARY OBJECTIVES:

I. To evaluate the preliminary efficacy of a lifestyle intervention in improving diet, physical activity, physical fitness, partner's support, quality of life, and inflammation at the end of the study (month 6).

II. To conduct a process evaluation of the lifestyle intervention. III. Explore participants' satisfaction, likes/dislikes, strengths, weaknesses, and areas of improvement regarding the program.

OUTLINE:

Participants receive an exercise plan and printed materials at baseline. Participants also receive 10 telephone coaching calls over 45-60 minutes weekly during month 1, every 2 weeks during month 2, and every month during months 3-6. Participants complete 2 nutrition counseling sessions before month 3.

Inclusion criteria

• Self-identify as black or African American or Hispanic (patient)
• Be greater than 18 years of age (patient and spouse or intimate partner)
• Have 0-III stage prostate cancer (patient)
• If treated, have completed therapy (e.g., surgery, chemo and/or radiation) (patient)
• Enroll with a spouse or intimate partner (patient)
• Do not meet physical activity recommendation (i.e., 150 minutes of moderate intensity physical activity per week) (patient and spouse or intimate partner)
• Be ready and able to be physically active, as determined by a physician (letter from a physician or nurse practitioner) (patient and spouse or intimate partner)
• Not participate in another physical activity, diet, or lifestyle program (patient)
• Have a valid home address and telephone number (patient)
• Internet access at home or other location (e.g., work, church, library, community center, etc.) (spouse or intimate partner)
• Patients on active surveillance will be included

Exclusion criteria

• They have an active noncutaneous malignancy at any site (patient)
• Had prior radiation therapy for treatment of the primary tumor (patient)
• Have planned concomitant immunotherapy, hormonal therapy, chemotherapy, or radiation therapy during the study period (patient)
• Are enrolled in another active surveillance protocol (patient)
• Participated in formative focus groups for this study (patient and spouse or intimate partner)